INVESTORS & MEDIA
SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Feb 5, 2018
Document Date
Dec 31, 2017
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Regeneron Pharmaceuticals Inc.
Issuer
REGENERON PHARMACEUTICALS, INC.
Filer
RYAN ARTHUR F